Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

National Cancer Institute (NCI) · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
brain-tumorcancerglioma
brain tumor, cancer, glioma, idh mutation, recurrent disease, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1044831
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.